{"id":"W2222086386","doi":"10.1056/nejmoa1510665","title":"Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma","year":2015,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5890,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Everolimus; Nivolumab; Renal cell carcinoma; Medicine; Oncology; Internal medicine; Cancer research; Urology; Immunotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}